Using coding and non-coding rare variants to target candidate genes in patients with severe tinnitus

Alvaro Gallego-Martinez1,2,3, Alba Escalera-Balsera4,5,6, Natalia Trpchevska7

  • 1Otology & Neurotology Group CTS495, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, 18016, Granada, Spain. alvaro.gallego@genyo.es.

NPJ Genomic Medicine
|November 30, 2022
PubMed
Summary

This study investigated genetic variants in tinnitus patients, identifying an enrichment of rare missense variants in genes like CACNA1E and NAV2, suggesting their role in the condition.